Enhanced Anticancer Efficiency of Curcumin Co-Loaded Lawsone Solid Lipid Nanoparticles Against MCF-7 Breast Cancer...

Area of Science:

• Pharmaceutical Sciences
• Nanotechnology
• Drug Delivery Systems

Background:

• Curcumin (CUR) and lawsone (LS) possess therapeutic potential but suffer from poor bioavailability.
• Developing effective delivery systems is crucial for enhancing the therapeutic efficacy of these compounds.

Purpose of the Study:

• To enhance the therapeutic effectiveness of curcumin (CUR) and lawsone (LS) by co-loading them into solid lipid nanoparticles (SLNs).
• To optimize the formulation of CUR-LS-SLN using independent variables like cetyl palmitate (CP), polyethylene glycol 400 (PEG), and probe sonication time (PS).

Main Methods:

• Solid lipid nanoparticles (SLNs) encapsulating CUR and LS were prepared using the hot emulsification method.
• Probe sonication was employed for nanoparticle formation, with cetyl palmitate (CP) and polyethylene glycol 400 (PEG) as key formulation components.
• Particle size and % entrapment efficiency (EE) were analyzed as critical dependent variables.

Main Results:

• The study successfully developed CUR-LS-SLN, optimizing formulation parameters.
• The developed SLNs showed promising particle size and high % entrapment efficiency (EE).
• The formulation approach suggests improved drug loading and stability.

Conclusions:

• Co-loading CUR and LS into SLNs is a viable strategy to enhance their therapeutic effectiveness.
• The optimized SLN formulation offers a promising platform for improved drug delivery.
• Further in vivo studies are warranted to confirm enhanced therapeutic outcomes.